ChartRow logo
PeersMRNALLYMDTUNHJNJTMO
Share this page

SEPN — Septerna Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0

Key stats#

Price data

Price
$39.35
YTD price return
+41.14%
YTD total return
+41.14%
Next earnings
Nov 9, 2026
Market cap
1.8B
Enterprise value
1.5B
Shares outstanding
46.7M
52W low
$17.55
52W high
$51.10
From 52W high
-22.99%
From 52W low
+124.22%
52W range
65%

Volume

Rel volume
1.05×
30D volume
398.4K
30D $ vol
15.1M

Fundamentals

Sales (ttm)
98.9M
Sales/share
$2.12
EPS (ttm)
-$0.54
FCF (ttm)
105.1M
FCF/share
$2.25
Book value/share
$8.29
Net margin
-24.51%
ROE
-6.27%
ROA
-4.28%
Current ratio
4.99

Growth (CAGR, ttm) · 10Y

Sales
+13566.03%+1242.29%n/an/a
Shares
+4.70%+193.69%n/an/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+12953.18%+357.04%n/an/a
Book value/share
-2.16%n/an/an/a
Price
+75.42%n/an/an/a
Total return
+75.42%n/an/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-73.1×
Fwd P/E
-18.8×
P/S (ttm)
18.6×
P/B (mrq)
4.7×
P/FCF (ttm)
17.5×
EV/Sales (ttm)
15.0×
FCF yield (ttm)
5.72%
Buyback yield (realized, 1y)
-4.70%
Shareholder yield (realized, 1y)
-4.70%
Buyback yield (cash, ttm)
-0.75%
Shareholder yield (cash, ttm)
-0.75%

Performance · price return · as of 2026-10-20#

1D
+8.16%
5D
+8.06%
1M
+1.71%
3M
+22.17%
YTD
+41.14%
1Y
+75.36%
5Y
—

Financial statements

Open full SEPN financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+11.34%+3.49%
JNJJohnson & Johnson-3.94%+2.19%
ABBVAbbVie Inc.+9.52%+2.26%
UNHUnitedHealth Group Incorporated Common Stock (DE)+11.24%+3.04%
MRKMerck & Co. Inc.+0.97%+3.25%
NVSNovartis AG+9.45%+2.29%
TMOThermo Fisher Scientific Inc.+5.51%+1.18%
AMGNAmgen Inc.+13.82%+3.29%